Company Filing History:
1 out of 832,891 Years Active: 2003
Title: John Huggins: Innovator in Eukaryotic Cell Line Technology
Introduction
John Huggins is a notable inventor based in Kent, GB. He has made significant contributions to the field of biotechnology, particularly in the design and use of eukaryotic cell lines. His work focuses on the identification of inhibitors of β-amyloid processing, which is crucial for understanding and potentially treating neurodegenerative diseases.
Latest Patents
Huggins holds a patent for "Assays for β-amyloid processing." This invention relates to the design, construction, and use of eukaryotic cell lines that are useful in identifying inhibitors of β-amyloid processing. More specifically, the patent describes in vitro assays capable of identifying or quantifying a 4.2 kDa β-amyloid protein. The invention also provides DNA and protein molecules that facilitate the design and construction of these eukaryotic cell lines.
Career Highlights
Throughout his career, John Huggins has demonstrated a commitment to advancing scientific knowledge and technology. His innovative approach to developing assays has positioned him as a key figure in the biotechnology sector. Huggins' work not only contributes to academic research but also has the potential to impact therapeutic strategies for diseases associated with β-amyloid.
Collaborations
John Huggins has collaborated with notable professionals in his field, including Rebecca Pruss and Guy Rautmann. These collaborations have enhanced the scope and impact of his research, fostering a collaborative environment that encourages innovation.
Conclusion
John Huggins is a distinguished inventor whose work in eukaryotic cell line technology has the potential to significantly advance our understanding of β-amyloid processing. His contributions to biotechnology are invaluable, and his patent reflects a commitment to innovation in the field.